Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
146.79
-0.97 (-0.65%)
Sep 1, 2026, 1:19 PM EDT - Market open
Protagonist Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates $149 | Buy | Reiterates | $149 | +1.51% | Sep 1, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 1, 2026 |
| Barclays | Barclays | Buy Maintains $153 → $180 | Buy | Maintains | $153 → $180 | +22.63% | Sep 1, 2026 |
| Clear Street | Clear Street | Buy Maintains $173 | Buy | Maintains | $173 | +17.86% | Sep 1, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $186 | Buy | Maintains | $186 | +26.72% | Sep 1, 2026 |
| Citi | Citi | Buy Maintains $175 → $182 | Buy | Maintains | $175 → $182 | +23.99% | Aug 31, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $165 → $170 | Buy | Maintains | $165 → $170 | +15.82% | Aug 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $167 → $170 | Buy | Reiterates | $167 → $170 | +15.82% | Aug 31, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.